Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.

@article{Platt2010CanWP,
  title={Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.},
  author={Alec B. Platt and A. Russell Localio and Colleen Brensinger and Dean G. Cruess and Jason D. Christie and Robert Gross and Catherine S Parker and Maureen Price and Joshua Metlay and Abigail Cohen and Craig W. Newcomb and Brian L. Strom and Mitchell S Laskin and Stephen E. Kimmel},
  journal={Chest},
  year={2010},
  volume={137 4},
  pages={883-9}
}
BACKGROUND Warfarin is the primary therapy to prevent stroke and venous thromboembolism. Significant periods of nonadherence frequently go unreported by patients and undetected by providers. Currently, no comprehensive screening tool exists to help providers assess the risk of nonadherence at the time of initiation of warfarin therapy. METHODS This article reports on a prospective cohort study of adults initiating warfarin therapy at two anticoagulation clinics (university- and Veterans… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
15 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…